Pay in 4 interest-free payments of $5.86 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Verify with your account administrator before purchasing, as some plans require prior documentation of medical necessity or provider authorization
GLP-1 receptor agonists have become recognized treatment options for T2D [19], which stimulate insulin and decrease glucagon secretion in a glucose-dependent manner, thereby improving glycemic control with a relatively low risk of hypoglycemia [20]
Additionally, some patients may possibly develop nutritional deficiencies particularly in protein, iron, or B vitaminsif their reduced food intake is not nutritionally balanced
Activation of GLP-1R triggers Gs-protein coupling leading to an elevation of cyclic AMP (cAMP), modulates intracellular calcium concentration 5 and induces -arrestin recruitment 6,7
US$ 20.73
US$ 24.42
US$ 21.70
US$ 22.64
